loading

Unity Biotechnology Inc Azioni (UBX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
1.02%
7.599
7.677 14.58 11.85 10.56
Interest Income/Expense
100.00%
-
0.001 0.566 0.883 1.002
Operating Income/Loss
1.02%
-7.599
-7.677 -14.58 -11.85 -10.56
Income/Loss From Continuing Operations Before Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Income/Loss From Continuing Operations After Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Net Income/Loss
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Diluted Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Basic Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Diluted Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.36
price down icon 1.39%
$39.11
price up icon 8.69%
$372.41
price up icon 1.09%
$23.09
price up icon 4.62%
biotechnology ONC
$215.13
price down icon 1.63%
$115.49
price down icon 1.75%
Capitalizzazione:     |  Volume (24 ore):